Affiliation:
1. Joslin Diabetes Center, Boston, MA
2. Harvard Medical School, Boston, MA
3. PlatformQ Health Education, Needham, MA
4. Thistle Editorial, LLC, Snoqualmie, WA
Abstract
Nonproliferative and proliferative diabetic retinopathy (DR) are common, progressive complications of diabetes with a rising incidence. Over time, patients with nonproliferative DR may progress to more advanced stages of DR, with an increased risk of vision-threatening conditions such as diabetic macular edema (DME). DME is the most frequent cause of vision loss in patients with diabetes and eventually can lead to blindness. Early-stage DR is asymptomatic; therefore, a coordinated management strategy is crucial to prevent or limit the progression of DR. Such a strategy includes regular screening for DR risk factors, glycemic control, and prompt diagnosis of DR. Preventive care should include a comprehensive dilated eye exam, ancillary tests, and patient education involving a multidisciplinary team composed of ophthalmologists, retina specialists, and primary diabetes care providers, including primary care providers and endocrinologists/diabetologists. However, although guideline recommendations for regular screening and patient education are well disseminated, many people with diabetes are not receiving ophthalmological care that could prevent visual impairment and blindness. We designed a mixed-methods study to explore the impact of patient-focused education on patient knowledge and self-efficacy in relation to DR prevention and management and to assess how online education can help to change patient knowledge, competence, and practice. Analysis of in-depth, qualitative data involving people with diabetes with or without DR collected 5–16 weeks after education participation shows that online patient education is an effective tool in building patient knowledge and awareness about DR and in motivating action in DR self-care.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference16 articles.
1. Centers for Disease Control and Prevention. National diabetes statistics report, 2014 [Internet]. Available from http://www.cdc.gov/diabetes/pubs/ statsreport14/national-diabetes-report-web.pdf. Accessed 21 June 2016
2. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies;Ciulla;Diabetes Care,2003
3. Prevalence and risk factors for diabetic macular edema in the United States;Varma;JAMA Ophthalmol,2014
4. American Academy of Ophthalmology. Diabetic retinopathy preferred practice pattern—2014 [Internet]. Available from http://one.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp–2014. Accessed 26 November 2014
5. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Diabetic Retinopathy Clinical Research Network;N Engl J Med,2015
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献